Table 2. Antitumour efficacy (ITT analysis, n=24).

Type of response	No.	%	95% CI
ORR	11	46	26–67
CR	1	4	0.1–21
PR	10	42	22–63
SD	4	17	5–37
Progressive disease	7	29	13–51
Not evaluable	2	8	1–27

ITT=intent-to-treat; CI=confidence interval; ORR=objective response rate; CR=complete response; PR=partial response; SD=stable disease.